fingolimod hydrochloride has been researched along with curcumol in 1 studies
Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (curcumol) | Trials (curcumol) | Recent Studies (post-2010) (curcumol) |
---|---|---|---|---|---|
2,771 | 157 | 2,062 | 115 | 1 | 95 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cao, P; Chai, S; Liu, J; Sun, S; Wang, Y; Wu, K; Xiao, X; Yan, H; Yang, C; Yuan, Y; Zhang, J; Zhao, M | 1 |
1 other study(ies) available for fingolimod hydrochloride and curcumol
Article | Year |
---|---|
Curcumol and FTY720 synergistically induce apoptosis and differentiation in chronic myelomonocytic leukemia via multiple signaling pathways.
Topics: Animals; Apoptosis; Cell Differentiation; Cell Proliferation; Disease Models, Animal; Fingolimod Hydrochloride; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Sesquiterpenes; Signal Transduction | 2021 |